Two views on suicide risk with antidepressants
The recent FDA proposal to force antidepressants to carry warnings about increased suicide risk is the subject of a pair of articles by leading experts in The Annals of Pharmacotherapy. According to “Antidepressants, Suicide, and the FDA: A Loose Association,” the FDA proposal is premature and may be counterproductive. The companion piece “Antidepressants: an Avoidable and Solvable Controversy” cautions the warnings simply don’t address the fundamental problem. Both articles are posted at The Annals of Pharmacotherapy’s Articles Ahead of Print (www.theannals.com) and will appear in the journal’s October issue.
Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.Like this author?
Catch up on other posts by John M. Grohol, PsyD (or subscribe to their feed).
Comments
This post currently has one comment. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
No trackbacks yet to this post.
Last reviewed: By John M. Grohol, Psy.D. on 24 Sep 2004
Published on PsychCentral.com. All rights reserved.
Grohol, J. (2004). Two views on suicide risk with antidepressants. Psych Central. Retrieved on February 14, 2012, from http://psychcentral.com/blog/archives/2004/09/24/two-views-on-suicide-risk-with-antidepressants/
